Multi-source Review Agent
Connect and reconcile relevant signals from CRONOS, EDC, CTMS, labs, operational data and approved source files.
PDFsExcelScanned copies
Clinical Aegis AgentsCoordinated agents.
Coordinated agents.
Controlled clinical action.
Aegis Agents work with CRONOS—and, where technically validated, with other systems and source files—to automate repetitive clinical activities, optimise review effort, surface risk and keep accountable experts in control.
Assess Study-Control Readiness →CLINICAL STUDY CONTROLSystems and evidence in. Coordinated agents at work.
CONNECTED SYSTEMS
CRONOSEDCCTMSLabseTMFOps
SOURCE FILES
PDFsExcelScanned copies
ORCHESTRATION & CONTROLAEGIS Agents
Review AgentMonitoring AgentRisk AgentReadiness AgentEvidence Agent
Optimise reviewPrioritised expert attention
Surface riskEvidence-linked signals
Improve readinessVisible issues and ownership
HUMAN OVERSIGHTAccountable clinical, data, medical and QA decisions
One coordinated agent group
Specialised agents work together across the clinical review cycle.
Each agent has a bounded responsibility. Orchestration, evidence links, workflow state and human review keep the group operating as one controlled system.
Central Monitoring Agent
Prioritise cross-site and cross-study indicators for expert monitoring review.
Risk & Signal Agent
Surface emerging patterns with the evidence and context needed to assess them.
Readiness Agent
Track unresolved review, reconciliation and ownership before critical milestones.
Evidence & Workflow Agent
Preserve source links, review states, decisions and accountable handoffs.
HUMAN-ACCOUNTABLE BY DESIGN
Clinical, data, medical and QA experts remain responsible for interpretation, decisions and approval.
High-value entry problems
Lead with review and oversight—not an AI transformation programme.
Manual review load
Experts spend too much time locating signals before they can apply judgment.
Late risk discovery
Study risk becomes visible only after fragmented indicators have already accumulated.
Fragmented oversight
Clinical, data, medical and QA teams often work from different slices of study context.
DB-lock pressure
Readiness depends on multiple review and reconciliation activities that need clearer evidence and ownership.
Connect without forced replacement
Work with CRONOS—or connect to the systems and source material already in place.
Each integration and file-ingestion pathway is validated for the deployed environment. Aegis Agents should not imply universal connectivity before the relevant interface and evidence path are technically demonstrated.
SYSTEMS & SOURCESCRONOSEDCCTMSLabseTMFOpsPDFsExcelScanned copies
→COORDINATED INTELLIGENCEAegis Agent Group
→CONTROLLED OUTCOMESReview priorityRisk oversightReadiness evidenceVisible ownership
Next step
Assess Study-Control Readiness →Start with one study-control problem.
Bring the current systems, source files, review queues, reconciliation burden and decision milestone. WHPL will focus the diagnostic on measurable evidence.